Understanding biofilm infections in diabetic foot ulcers
Official title: Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
Run by University of Pittsburgh · NCT05172089 · Data updated 2026-11-12
This study looks at how biofilm infections in diabetic foot ulcers affect healing and whether they make wounds more likely to come back.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 405 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 2 sites (Tucson, Arizona and 1 other locations) |
| Status | Recruiting |
| Started | April 2, 2024 |
| Main results expected | June 27, 2028 |
| Study ends | June 27, 2029 |
| Registry record updated | March 18, 2026 |
| Trial ID | NCT05172089 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with an open diabetic foot ulcer and adequate arterial blood flow.
✕Probably not a fit
Patients with closed wounds, significant immunodeficiency, or those unable to comply with study procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with diabetic foot ulcers (DFU) to investigate the relationship between biofilm infections and wound healing. It aims to determine if DFUs with a history of biofilm infection exhibit deficient barrier function, as indicated by high trans-epidermal water loss (TEWL), and whether this deficiency is linked to increased rates of wound recurrence. The study will also explore the molecular mechanisms behind biofilm-induced loss of skin barrier integrity in DFU patients. By analyzing these factors, the research seeks to improve understanding and management of chronic wounds in diabetic patients.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for diabetic foot ulcers, reducing the risk of recurrence and amputations.
How similar studies have gone: While biofilm infections in chronic wounds have been studied, this specific approach focusing on functional wound closure in DFUs is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or Female, Age ≥ 18 * Willing to comply with protocol instructions, including all study visits and study activities. * Patient with an open Diabetic Foot Ulcer * Adequate arterial blood flow as evidenced by at least one of the following (for wounds below the knee): * TcOM \>30 mmHg * Ankle-brachial index at least ≥0.7 * Toe pressure \> 30 mmHg * TBI \> 0.6 mmHg Exclusion Criteria: * Individuals who are deemed unable to understand the procedures, risks, and benefits of the study. * Wounds closed or to be surgically closed by flap or graft coverage * Subjects with marked immunodeficiency (HIV/AIDS, or on immunosuppressive medications. * TcOM \< 30mmHg * Diabetics with a hemoglobin A1c \> 15 within 3 months prior to enrollment * Subject with autoimmune connective tissue disease * Ulcer size and location that does not allow the TEWL measurement per SOP * Pregnant women * Prisoners * Unable to comply with study procedures and/or complete study visits
Where it's running
-
University of Arizona
Tucson, Arizona, United States Recruiting -
UPMC Wound Healing Services at UPMC Passavant
Cranberry Township, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Chandan K Sen, PhD — University of Pittsburgh
- Study coordinator: Piya Das Ghatak, PhD, MS
- Email: piya.dasghatak@pitt.edu
- Phone: 4126240422
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Miro3D Wound Matrix for Diabetic Foot Ulcers
This study tests whether adding Miro3D Wound Matrix to standard care helps healing diabetic foot ulcers in adults.
-
Using stem cells from fat to treat diabetic foot ulcers
This study is testing if using stem cells from fat, along with a special blood product, can help heal chronic foot ulcers in people with diabetes.
-
Continuous temperature monitoring of the feet with connected insoles and a smartphone app in adults with diabetes at high risk
This trial tests whether the Solsius SelfCare system can reliably flag pre-ulcer foot changes in adults with diabetes by detecting temperature differences between feet for at least two consecutive days.
-
Coordinated primary-care MDT approach for hard-to-heal ulcers
A group of adults with hard-to-heal diabetic foot ulcers will be randomly assigned to standard care or a coordinated multidisciplinary team to see if the team approach helps ulcers heal better.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
See if Hyalomatrix helps heal venous leg ulcers faster when added to standard care
This trial tests whether adding Hyalomatrix to standard wound care helps people with venous leg ulcers heal more effectively.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.